The Orphan Nuclear Receptor SHP Inhibits Hepatocyte Nuclear Factor 4 and Retinoid X Receptor Transactivation: Two Mechanisms for Repression

REFERENCES

• Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X. Y., Sauter, G., Kallioniemi, O. P., Trent, J. M., and Meltzer, P. S.. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965–968
   PubMed Web of Science ®Google Scholar
• Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K.. 1999. Current protocols in molecular biology. J. Wiley & Sons, New York, N.Y
   Google Scholar
• Bannister, A. J., and Kouzarides, T.. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641–643
   PubMed Web of Science ®Google Scholar
• Berk, A. J.. 1999. Activation of RNA polymerase II transcription. Curr. Opin. Cell Biol. 11:330–335
   PubMedGoogle Scholar
• Blanco, J. C., Minucci, S., Lu, J., Yang, X. J., Walker, K. K., Chen, H., Evans, R. M., Nakatani, Y., and Ozato, K.. 1998. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 12:1638–1651
   PubMed Web of Science ®Google Scholar
• Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., and Evans, R. M.. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569–580
   PubMed Web of Science ®Google Scholar
• Danielian, P. S., White, R., Lee, J. A., and Parker, M. G.. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1025–1033
   PubMed Web of Science ®Google Scholar
• Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J., and Yamamoto, K. R.. 1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:3343–3356
   PubMed Web of Science ®Google Scholar
• Dell, H., and Hadzopoulou-Cladaras, M.. 1999. CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J. Biol. Chem. 274:9013–9021
   PubMed Web of Science ®Google Scholar
• Enmark, E., and Gustafsson, J. A.. 1996. Orphan nuclear receptors—the first eight years. Mol. Endocrinol. 10:1293–1307
   PubMedGoogle Scholar
• Forman, B. M., Umesono, K., Chen, J., and Evans, R. M.. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541–550
   PubMed Web of Science ®Google Scholar
• Hadzopoulou-Cladaras, M., Kistanova, E., Evagelopoulou, C., Zeng, S., Cladaras, C., and Ladias, J. A.. 1997. Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J. Biol. Chem. 272:539–550
   PubMed Web of Science ®Google Scholar
• Hong, H., Kohli, K., Garabedian, M. J., and Stallcup, M. R.. 1997. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17:2735–2744
   PubMed Web of Science ®Google Scholar
• Horwitz, K. B., Jackson, T. A., Bain, D. L., Richer, J. K., Takimoto, G. S., and Tung, L.. 1996. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1167–1177
   PubMed Web of Science ®Google Scholar
• Ito, M., Yu, R., and Jameson, J. L.. 1997. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17:1476–1483
   PubMed Web of Science ®Google Scholar
• Jiang, G., Lee, U., and Sladek, F. M.. 1997. Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization. Mol. Cell. Biol. 17:6546–6554
   PubMedGoogle Scholar
• Johansson, L., Thomsen, J. S., Damdimopoulos, A. E., Spyrou, G., Gustafsson, J., and Treuter, E.. 1999. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J. Biol. Chem. 274:345–353
   PubMedGoogle Scholar
• Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S. C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G.. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403–414
   PubMed Web of Science ®Google Scholar
• Lalli, E., Bardoni, B., Zazopoulos, E., Wurtz, J.-M., Strom, T. M., Moras, D., and Sassone-Corsi, P.. 1997. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol. Endocrinol. 11:1950–1960
   PubMedGoogle Scholar
• Lee, Y. K., Parker, K. L., Choi, H. S., and Moore, D. D.. 1999. Activation of the promoter of the orphan receptor SHP by orphan receptors that bind DNA as monomers. J. Biol. Chem. 274:20869–20873
   PubMedGoogle Scholar
• Leng, X., Blanco, J., Tsai, S. Y., Ozato, K., O'Malley, B. W., and Tsai, M. J.. 1995. Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol. Cell. Biol. 15:255–263
   PubMed Web of Science ®Google Scholar
• Li, H., Gomes, P. J., and Chen, J. D.. 1997. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. USA 94:8479–8484
   PubMed Web of Science ®Google Scholar
• Mangelsdorf, D. J., and Evans, R. M.. 1995. The RXR heterodimers and orphan receptors. Cell 83:841–850
   PubMed Web of Science ®Google Scholar
• Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. M.. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835–839
   PubMed Web of Science ®Google Scholar
• Nakshatri, H., and Chambon, P.. 1994. The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF-4, and ARP-1 homo- and heterodimers. J. Biol. Chem. 269:890–902
   PubMed Web of Science ®Google Scholar
• Nawaz, Z., Lonard, D. M., Smith, C. L., Lev-Lehman, E., Tsai, S. Y., Tsai, M.-J., and O'Malley, B. W.. 1999. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19:1182–1189
   PubMed Web of Science ®Google Scholar
• Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., and Milburn, M. V.. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395:137–143
   PubMed Web of Science ®Google Scholar
• Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., and Nakatani, Y.. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959
   PubMed Web of Science ®Google Scholar
• Onate, S. A., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W.. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354–1357
   PubMed Web of Science ®Google Scholar
• Renaud, J. P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., and Moras, D.. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681–689
   PubMed Web of Science ®Google Scholar
• Reutens, A. T., Achermann, J. C., Ito, M., Gu, W. X., Habiby, R. L., Donohoue, P. A., Pang, S., Hindmarsh, P. C., and Jameson, J. L.. 1999. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J. Clin. Endocrinol. Metab. 84:504–511
   PubMedGoogle Scholar
• Seol, W., Choi, H. S., and Moore, D. D.. 1996. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336–1339
   PubMed Web of Science ®Google Scholar
• Seol, W., Chung, M., and Moore, D. D.. 1997. Novel receptor interaction and repression domains in the orphan receptor SHP. Mol. Cell. Biol. 17:7126–7131
   PubMed Web of Science ®Google Scholar
• Seol, W., Hanstein, B., Brown, M., and Moore, D. D.. 1998. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol. Endocrinol. 12:1551–1557
   PubMedGoogle Scholar
• Seol, W., Mahon, M. J., Lee, Y. K., and Moore, D. D.. 1996. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol. Endocrinol. 10:1646–1655
   PubMedGoogle Scholar
• Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., and Greene, G. L.. 1998. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927–937
   PubMed Web of Science ®Google Scholar
• Shibata, H., Spencer, T. E., Onate, S. A., Jenster, G., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W.. 1997. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52:141–164
   PubMedGoogle Scholar
• Sladek, F. M., Zhong, W., Lai, E., and Darnell, J. J. E.. 1990. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4:2353–2365
   PubMed Web of Science ®Google Scholar
• Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W.. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194–198
   PubMed Web of Science ®Google Scholar
• Takeshita, A., Cardona, G. R., Koibuchi, N., Suen, C. S., and Chin, W. W.. 1997. TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 272:27629–27634
   PubMedGoogle Scholar
• Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., and Rosenfeld, M. G.. 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677–684
   PubMed Web of Science ®Google Scholar
• Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P., and Gronemeyer, H.. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:3667–3675
   PubMed Web of Science ®Google Scholar
• Wagner, R. L., Apriletti, J. W., McGrath, M. E., West, B. L., Baxter, J. D., and Fletterick, R. J.. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690–697
   PubMed Web of Science ®Google Scholar
• Wang, J. C., Stafford, J. M., and Granner, D. K.. 1998. SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J. Biol. Chem. 273:30847–30850
   PubMed Web of Science ®Google Scholar
• Wotton, D., Lo, R. S., Lee, S., and Massague, J.. 1999. A Smad transcriptional corepressor. Cell 97:29–39
   PubMed Web of Science ®Google Scholar
• Wurtz, J. M., Bourguet, W., Renaud, J. P., Vivat, V., Chambon, P., Moras, D., and Gronemeyer, H.. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol. 3:87–94
   PubMedGoogle Scholar
• Xu, L., Glass, C. K., and Rosenfeld, M. G.. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9:140–147
   PubMed Web of Science ®Google Scholar
• Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M., and Bell, G. I.. 1996. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384:458–460
   PubMed Web of Science ®Google Scholar
• Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H., and Nakatani, Y.. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319–324
   PubMed Web of Science ®Google Scholar
• Zanaria, E., Muscatelli, F., Bardoni, B., Strom, T. M., Guioli, S., Guo, W., Lalli, E., Moser, C., Walker, A. P., McCabe, E. R. B., Meitinger, T., Monaco, A. P., Sassone-Corsi, P., and Camerino, G.. 1994. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635–641
   PubMed Web of Science ®Google Scholar
• Zavacki, A. M., Lehmann, J. M., Seol, W., Willson, T. M., Kliewer, S. A., and Moore, D. D.. 1997. Activation of the orphan receptor RIP14 by retinoids. Proc. Natl. Acad. Sci. USA 94:7909–7914
   PubMedGoogle Scholar
• Zhang, X.-K., Salbert, G., Lee, M.-O., and Pfahl, M.. 1994. Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor. Mol. Cell. Biol. 14:4311–4323
   PubMedGoogle Scholar
• Zhang, Y. H., Guo, W., Wagner, R. L., Huang, B. L., McCabe, L., Vilain, E., Burris, T. P., Anyane-Yeboa, K., Burghes, A. H., Chitayat, D., Chudley, A. E., Genel, M., Gertner, J. M., Klingensmith, G. J., Levine, S. N., Nakamoto, J., New, M. I., Pagon, R. A., Pappas, J. G., Quigley, C. A., Rosenthal, I. M., Baxter, J. D., Fletterick, R. J., and McCabe, E. R.. 1998. DAX1 mutations map to putative structural domains in a deduced three-dimensional model. Am. J. Hum. Genet. 62:855–864
   PubMedGoogle Scholar